Roberto Giugliani Selected Research

Iduronidase (alpha-L-Iduronidase)

1/2022	Brain and visceral gene editing of mucopolysaccharidosis I mice by nasal delivery of the CRISPR/Cas9 system.
1/2021	Cardiac pathology in mucopolysaccharidosis I mice: Losartan modifies ERK1/2 activation during cardiac remodeling.
1/2021	Gene Therapy of Mucopolysaccharidosis Type I Mice: Repeated Administrations and Safety Assessment of pIDUA/Nanoemulsion Complexes.
3/2020	Mucopolysaccharidosis Type I.
1/2020	Neonatal nonviral gene editing with the CRISPR/Cas9 system improves some cardiovascular, respiratory, and bone disease features of the mucopolysaccharidosis I phenotype in mice.
1/2020	Progressive eye pathology in mucopolysaccharidosis type I mice and effects of enzyme replacement therapy.
10/2019	Genotype-phenotype relationships in mucopolysaccharidosis type I (MPS I): Insights from the International MPS I Registry.
10/2018	In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system.
4/2018	Plasma Pharmacokinetics of Valanafusp Alpha, a Human Insulin Receptor Antibody-Iduronidase Fusion Protein, in Patients with Mucopolysaccharidosis Type I.
1/2018	Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roberto Giugliani Research Topics

Disease

49	Mucopolysaccharidoses 01/2022 - 01/2004
39	Mucopolysaccharidosis I (Hurler Syndrome) 01/2022 - 01/2002
34	Mucopolysaccharidosis II (Hunter Syndrome) 10/2021 - 08/2006
29	Fabry Disease (Fabry's Disease) 12/2021 - 09/2006
23	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2022 - 04/2004
21	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2022 - 01/2003
20	Mucopolysaccharidosis IV (Morquio Syndrome) 02/2019 - 01/2004
18	Inborn Genetic Diseases (Disease, Hereditary) 09/2022 - 03/2010
10	Gaucher Disease (Gaucher's Disease) 01/2021 - 05/2004
9	Niemann-Pick Diseases (Niemann Pick Disease) 01/2022 - 08/2004
7	Disease Progression 03/2022 - 04/2005
6	GM1 Gangliosidosis (Gangliosidosis GM1) 03/2022 - 01/2011
6	Rare Diseases (Rare Disease) 10/2021 - 09/2011
6	Mucolipidoses (Sialidosis) 01/2020 - 08/2004
5	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 03/2022 - 12/2008
5	Cognitive Dysfunction 01/2021 - 01/2012
5	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2021 - 01/2006
5	Mucopolysaccharidosis VII (Sly Syndrome) 01/2021 - 09/2012
5	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 09/2006
5	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 12/2016 - 09/2006
4	Inflammation (Inflammations) 01/2022 - 02/2012
4	Splenomegaly 01/2022 - 08/2008
4	Heart Diseases (Heart Disease) 01/2021 - 09/2014
3	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2022 - 05/2010
3	Diarrhea 01/2019 - 09/2014
3	Neoplasms (Cancer) 01/2019 - 02/2008
3	Congenital Abnormalities (Deformity) 02/2015 - 05/2010
3	Phenylketonurias (Phenylketonuria) 05/2011 - 05/2003
3	Demyelinating Diseases (Demyelinating Disease) 03/2008 - 11/2007
2	GM2 Gangliosidoses (GM2 Gangliosidosis) 03/2022 - 11/2006
2	Sphingolipidoses (Sphingolipidosis) 03/2022 - 07/2005
2	Cardiomyopathies (Cardiomyopathy) 01/2022 - 06/2015
2	Brain Diseases (Brain Disorder) 08/2021 - 12/2017
2	Exanthema (Rash) 01/2021 - 01/2009
2	Urticaria (Hives) 01/2021 - 01/2009
2	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 12/2020 - 01/2016
2	Sleep Wake Disorders 01/2019 - 01/2019
2	Maple Syrup Urine Disease 01/2019 - 04/2009
2	Proteinuria 03/2018 - 01/2009
2	Melanoma (Melanoma, Malignant) 01/2016 - 02/2008
2	Intellectual Disability (Idiocy) 02/2015 - 04/2007
2	Breast Neoplasms (Breast Cancer) 06/2012 - 01/2011
2	Hypertrophy 12/2011 - 07/2006

Drug/Important Bio-Agent (IBA)

83	EnzymesIBA 09/2022 - 01/2002
65	GlycosaminoglycansIBA 01/2022 - 04/2005
28	Iduronidase (alpha-L-Iduronidase)IBA 01/2022 - 01/2002
16	GalactosidasesIBA 12/2019 - 07/2011
14	Biomarkers (Surrogate Marker)IBA 03/2022 - 08/2012
14	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 01/2022 - 01/2003
10	idursulfase FDA Link 10/2021 - 08/2006
9	SulfatasesIBA 05/2018 - 01/2003
8	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2006
7	migalastatIBA 12/2021 - 08/2016
7	AcidsIBA 01/2019 - 03/2008
7	Dermatan SulfateIBA 06/2018 - 01/2003
7	Keratan SulfateIBA 05/2015 - 01/2004
6	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022 - 06/2011
6	Lysergic Acid Diethylamide (LSD)IBA 01/2019 - 08/2004
6	globotriaosylceramide (globotriosylceramide)IBA 01/2019 - 02/2012
6	Fatty Acids (Saturated Fatty Acids)IBA 03/2010 - 09/2006
5	Pharmaceutical PreparationsIBA 03/2022 - 01/2009
5	GlucuronidaseIBA 01/2021 - 09/2012
5	LipidsIBA 01/2021 - 08/2008
5	Biological ProductsIBA 12/2019 - 09/2006
4	Cerebroside-Sulfatase (Arylsulfatase A)IBA 03/2022 - 12/2008
4	DNA (Deoxyribonucleic Acid)IBA 11/2018 - 03/2012
4	CreatinineIBA 03/2018 - 04/2004
4	human GALNS proteinIBA 01/2018 - 11/2014
4	GlycosphingolipidsIBA 12/2015 - 05/2004
3	agalsidase alfaIBA 01/2022 - 01/2009
3	Bile Acids and Salts (Bile Acids)IBA 12/2020 - 06/2014
3	HydrolasesIBA 12/2019 - 01/2017
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2019 - 01/2016
3	CytokinesIBA 01/2016 - 12/2010
3	Chondroitin Sulfates (Chondroitin Sulfate)IBA 05/2015 - 01/2003
3	AntioxidantsIBA 03/2008 - 09/2006
3	chitotriosidaseIBA 03/2007 - 05/2004
3	beta-GlucosidaseIBA 12/2005 - 05/2004
2	SphingolipidsIBA 03/2022 - 12/2020
2	Sulfoglycosphingolipids (Sulfatides)IBA 03/2022 - 01/2020
2	olipudase alfaIBA 01/2022 - 01/2021
2	Therapeutic UsesIBA 01/2022 - 01/2009
2	Carbon MonoxideIBA 01/2022 - 09/2020
2	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 01/2017
2	CholesterolIBA 12/2020 - 01/2016
2	valanafusp alphaIBA 04/2018 - 01/2018
2	Insulin ReceptorIBA 04/2018 - 01/2018
2	alpha-Galactosidase (Beano)IBA 03/2018 - 01/2008
2	Cathepsin BIBA 03/2018 - 03/2017
2	SphingomyelinsIBA 01/2018 - 01/2016
2	neodymium pyrocatechin disulfonate (NPD)IBA 01/2016 - 10/2004
2	ArylsulfatasesIBA 09/2014 - 12/2011
2	CollagenIBA 11/2013 - 10/2013
2	Iduronic Acid (Iduronate)IBA 09/2013 - 06/2011
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2013 - 07/2005
2	Free RadicalsIBA 06/2011 - 09/2006

Therapy/Procedure

59	Enzyme Replacement Therapy 01/2022 - 06/2005
23	Therapeutics 03/2022 - 09/2006
9	Hematopoietic Stem Cell Transplantation 01/2019 - 12/2011
2	Transplantation 10/2017 - 12/2010